Clinical trial
Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients
NCT05319093 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Observational
- Overall status
- Terminated
- Start date
- April 1, 2022
- Completion date
- July 23, 2024
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.